Literature DB >> 528273

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin.

P R Twentyman, R F Kallman, J M Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 528273     DOI： 10.1016/0360-3016(79)90649-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  21 in total

1.  Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.

Authors:  M I Walton; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  CB 1954 revisited. II. Toxicity and antitumour activity.

Authors:  P Workman; J E Morgan; K Talbot; K A Wright; J Donaldson; P R Twentyman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  CB 1954 revisited. I. Disposition kinetics and metabolism.

Authors:  P Workman; R A White; K Talbot
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.

Authors:  F Y Lee; P Coe; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in mice.

Authors:  M I Walton; N M Bleehen; P Workman
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

6.  Preclinical pharmacokinetics of benznidazole.

Authors:  P Workman; R A White; M I Walton; L N Owen; P R Twentyman
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

7.  The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.

Authors:  P R Twentyman; P Workman; K A Wright; N M Bleehen
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

8.  Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.

Authors:  F Y Lee; P Workman
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

9.  Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.

Authors:  P R Twentyman
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

10.  Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.

Authors:  J M Brown; D G Hirst
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.